Macquarie University, North Ryde, NSW, Australia.
Liverpool Hospital, Liverpool, NSW, Australia.
Colorectal Dis. 2021 Apr;23(4):937-943. doi: 10.1111/codi.15455. Epub 2020 Dec 20.
Natural orifice specimen extraction (NOSE) challenges the limits of minimally invasive colorectal surgery by exploiting a natural opening for specimen delivery. Technically challenging, it is less painful, requires smaller wounds and abolishes the possibility of incisional hernia. These advantages of NOSE are seen in the obese (body mass index [BMI] >30 kg/m ). This audit aims to demonstrate the feasibility of NOSE colectomy in an Australian population.
Prospective data collected from 2007 to the present were retrospectively analysed. Only patients with mucosally benign colorectal conditions were included: complex diverticulosis, post-malignant polypectomy and volvulus. Left sided mucosal malignancies were excluded. Study end-points included postoperative length of stay, anastomotic leak rate and wound complications.
In total, 159 patients underwent NOSE, mean age 59 years (19-88), mean BMI 28.2 kg/m (17-45). Ten (6.2%) patients developed retroperitoneal small bowel herniation; seven required further surgery. There were five (3.1%) anastomotic leaks, seven (4.4%) postoperative ileus and three (1.9%) anastomotic bleeds. One (0.6%) patient had a superficial wound infection. There were no port site hernias. Patients with BMI <30 kg/m (98 patients) and BMI >30 kg/m (59 patients) were compared; there was no difference in anastomotic leak rate (P = 0.60), complication rate (P = 0.71) and length of stay (P = 0.63). However, duration of operation increased with BMI (P = 0.000).
This large series of NOSE colectomy from Australia suggests that NOSE is comparable to conventional laparoscopic colectomy in terms of postoperative outcome. Given that obesity has not featured in the NOSE literature, our study suggests that NOSE, for benign disease, is safe in obese patients, without added morbidity.
自然腔道标本取出术(NOSE)通过利用自然开口来递送标本,从而挑战了微创结直肠手术的极限。该技术具有挑战性,疼痛程度较低,需要的伤口更小,并消除了切口疝的可能性。NOSE 的这些优势在肥胖患者(体重指数[BMI]>30kg/m²)中可见。本研究旨在证明 NOSE 结肠切除术在澳大利亚人群中的可行性。
回顾性分析了 2007 年至今前瞻性收集的数据。仅纳入结直肠黏膜良性病变患者:复杂憩室病、恶性息肉切除术后和肠扭转。排除左侧黏膜恶性肿瘤患者。研究终点包括术后住院时间、吻合口漏发生率和伤口并发症。
共 159 例患者接受了 NOSE 手术,平均年龄 59 岁(19-88 岁),平均 BMI 28.2kg/m²(17-45kg/m²)。10 例(6.2%)患者发生腹膜后小肠疝,7 例需要进一步手术。吻合口漏 5 例(3.1%),术后肠梗阻 7 例(4.4%),吻合口出血 3 例(1.9%)。1 例(0.6%)患者出现浅表伤口感染。无端口疝。比较 BMI<30kg/m²(98 例)和 BMI>30kg/m²(59 例)患者,吻合口漏发生率(P=0.60)、并发症发生率(P=0.71)和住院时间(P=0.63)无差异。然而,BMI 与手术时间呈正相关(P=0.000)。
本项来自澳大利亚的大量 NOSE 结肠切除术系列研究表明,NOSE 在术后结果方面与传统腹腔镜结肠切除术相当。鉴于肥胖并未在 NOSE 文献中出现,我们的研究表明,对于良性疾病,NOSE 在肥胖患者中是安全的,不会增加发病率。